These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 28592412)
1. Polypill is not just for cardiovascular disease. Cafferty FH; Langley RE BMJ; 2017 Jun; 357():j2733. PubMed ID: 28592412 [No Abstract] [Full Text] [Related]
3. One Pill for Everyone? Twenty Years of Polypill for Cardiovascular Disease. Tran RJC Am J Cardiol; 2023 Sep; 203():493-495. PubMed ID: 37500317 [No Abstract] [Full Text] [Related]
4. The polypill and medicines access: two decades and counting. Rodgers A; Smith R BMJ; 2023 Aug; 382():1847. PubMed ID: 37562792 [No Abstract] [Full Text] [Related]
5. The polypill: from concept and evidence to implementation. Yusuf S; Pinto FJ Lancet; 2022 Nov; 400(10364):1661-1663. PubMed ID: 36243022 [No Abstract] [Full Text] [Related]
6. A Meta-analysis of the Use of Polypill for Secondary Prevention of Atherosclerotic Cardiovascular Disease. Al-Abdouh A; Mhanna M; Jabri A; Ahmed T; Altibi AM; Ghanem F; Alhuneafat L; Mostafa MR; Abusnina W; Dewaswala N; Bhopalwala H; Kundu A; Michos ED Am J Ther; 2024 Mar-Apr 01; 31(2):e193-e195. PubMed ID: 36857708 [No Abstract] [Full Text] [Related]
7. A SECURE polypill as a strategy at the heart of secondary prevention. Liuzzo G; Patrono C Eur Heart J; 2022 Nov; 43(43):4534-4535. PubMed ID: 36148477 [No Abstract] [Full Text] [Related]
8. Scientific development of the CNIC cardiovascular polypill: from conceptualization to clinical efficacy. Castellano JM; Fuster V Rev Esp Cardiol (Engl Ed); 2023 Dec; 76(12):1055-1060. PubMed ID: 37866619 [No Abstract] [Full Text] [Related]
9. Polypill Better for Secondary Cardiovascular Prevention Than Physician-Directed Care. Ebell MH Am Fam Physician; 2023 Mar; 107(3):318-319. PubMed ID: 36920802 [No Abstract] [Full Text] [Related]
10. [The Polypill - A Practicable Approach?]. Thürmann PA; Kleinerüschkamp AG; Boehme P Dtsch Med Wochenschr; 2019 Jun; 144(11):715-718. PubMed ID: 31163467 [TBL] [Abstract][Full Text] [Related]
11. Polypill for cardiovascular disease prevention. Dalton AR JAMA; 2013 Aug; 310(7):749. PubMed ID: 23989135 [No Abstract] [Full Text] [Related]
12. Polypill for cardiovascular disease prevention--reply. Smith R; McCready T; Yusuf S JAMA; 2013 Aug; 310(7):749-50. PubMed ID: 23989317 [No Abstract] [Full Text] [Related]
13. Embracing the polypill as a cardiovascular therapeutic: is this the best strategy? Franczyk B; Gluba-Brzózka A; Jurkiewicz Ł; Penson P; Banach M; Rysz J Expert Opin Pharmacother; 2018 Dec; 19(17):1857-1865. PubMed ID: 30295098 [TBL] [Abstract][Full Text] [Related]
14. Strengths and Limitations of Using the Polypill in Cardiovascular Prevention. Roy A; Naik N; Srinath Reddy K Curr Cardiol Rep; 2017 May; 19(5):45. PubMed ID: 28425033 [TBL] [Abstract][Full Text] [Related]
15. [Polypill for cardiovascular disease prevention: the SECURE study]. Di Fusco SA; Colivicchi F G Ital Cardiol (Rome); 2023 May; 24(5):333-335. PubMed ID: 37102344 [No Abstract] [Full Text] [Related]
16. Is Polypill the magic pill? Maggioni AP Int J Cardiol; 2022 Oct; 364():139-140. PubMed ID: 35700855 [No Abstract] [Full Text] [Related]
17. The polypill from a public-health perspective. Feigin VL; Brainin M; Martins SCO Lancet Neurol; 2023 Apr; 22(4):294-295. PubMed ID: 36931800 [No Abstract] [Full Text] [Related]
18. Information regarding polypill treatment is lacking. Dufour I; Devresse A Kidney Int; 2023 Jun; 103(6):1201. PubMed ID: 37210198 [No Abstract] [Full Text] [Related]
19. Letter by Mascitelli and Goldstein Regarding Article, "Is Statin Monotherapy the Perfect Polypill?". Mascitelli L; Goldstein MR Circulation; 2016 Nov; 134(21):e503-e504. PubMed ID: 27881516 [No Abstract] [Full Text] [Related]
20. Improving cardiovascular protection: focus on a cardiovascular polypill. Barrios V; Escobar C Future Cardiol; 2016 Mar; 12(2):181-96. PubMed ID: 26652213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]